TipRanks
Go Ultimate55% OFF

Comparison Results

Comparison results
NamePricePrice ChangePrice TargetSmart ScoreExpense RatioAsset Under ManagementFollow
PBPHPortfolio Building Block World Pharma and Biotech Index ETF$31.35$32.90(4.96% Upside)0.13%1.17B
CANCTema Oncology ETF$42.29$60.99(44.23% Upside)0.75%216.18M
LFSCF/M Emerald Life Sciences Innovation ETF$43.60$66.87(53.39% Upside)0.54%125.43M
IBBQInvesco Nasdaq Biotechnology ETF$36.17$45.87(26.80% Upside)0.19%120.43M
HRTSTema Cardiovascular and Metabolic ETF$38.87$45.45(16.91% Upside)0.75%57.10M
OZEMRoundhill GLP-1 & Weight Loss ETF$30.70$48.04(56.51% Upside)0.59%55.57M
PSILAdvisorShares Psychedelics ETF$21.00$55.08(162.26% Upside)1.00%46.62M
THNRAmplify Weight Loss Drug & Treatment ETF$25.95$35.47(36.72% Upside)0.59%5.83M
BIBProShares Ultra Nasdaq Biotechnology$120.53―0.95%103.75M
BISProShares UltraShort Nasdaq Biotechnology$10.47―0.95%1.73M

Performance Comparison

-50%0%50%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
PBPHPortfolio Building Block World Pharma and Biotech Index ETF31.356.3025.14%
CANCTema Oncology ETF42.2911.6538.04%
LFSCF/M Emerald Life Sciences Innovation ETF43.6011.3135.02%
IBBQInvesco Nasdaq Biotechnology ETF36.1710.1138.81%
HRTSTema Cardiovascular and Metabolic ETF38.876.9621.81%
OZEMRoundhill GLP-1 & Weight Loss ETF30.702.027.03%
PSILAdvisorShares Psychedelics ETF21.003.7721.91%
THNRAmplify Weight Loss Drug & Treatment ETF25.953.0913.52%
BIBProShares Ultra Nasdaq Biotechnology120.5351.0573.47%
BISProShares UltraShort Nasdaq Biotechnology10.47-10.94-51.10%

ETFs Similar to IBRN FAQ

What is the cheapest alternative to IBRN?
Among the ETFs similar to IBRN, PBPH (Portfolio Building Block World Pharma and Biotech Index ETF) has the lowest expense ratio, at 0.13% a year, compared with 0.47% for IBRN.
IBRN vs. PBPH: what is the difference?
PBPH (Portfolio Building Block World Pharma and Biotech Index ETF) is the first ETF in IBRN's similar-ETF list. It has $1.17B in assets under management and a 0.13% expense ratio, against $6.66M and 0.47% for IBRN. Compare their performance, price targets and Smart Scores in the table above.